Aurobindo Pharma Statistics

Total Valuation

BOM:524804 has a market cap or net worth of INR 668.04 billion. The enterprise value is 668.25 billion.

Market Cap	668.04B
Enterprise Value	668.25B

Important Dates

The last earnings date was Wednesday, May 28, 2025.

Earnings Date	May 28, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	580.80M
Shares Outstanding	n/a
Shares Change (YoY)	-0.53%
Shares Change (QoQ)	-0.05%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	272.90M

Valuation Ratios

The trailing PE ratio is 19.16 and the forward PE ratio is 16.54.

PE Ratio	19.16
Forward PE	16.54
PS Ratio	2.11
PB Ratio	2.05
P/TBV Ratio	2.35
P/FCF Ratio	34.14
P/OCF Ratio	17.02
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 10.17, with an EV/FCF ratio of 34.15.

EV / Earnings	19.17
EV / Sales	2.11
EV / EBITDA	10.17
EV / EBIT	13.57
EV / FCF	34.15

Financial Position

The company has a current ratio of 1.85, with a Debt / Equity ratio of 0.25.

Current Ratio	1.85
Quick Ratio	0.95
Debt / Equity	0.25
Debt / EBITDA	1.25
Debt / FCF	4.22
Interest Coverage	10.84

Financial Efficiency

Return on equity (ROE) is 11.15% and return on invested capital (ROIC) is 8.00%.

Return on Equity (ROE)	11.15%
Return on Assets (ROA)	6.53%
Return on Invested Capital (ROIC)	8.00%
Return on Capital Employed (ROCE)	14.12%
Revenue Per Employee	12.19M
Profits Per Employee	1.34M
Employee Count	26,015
Asset Turnover	0.67
Inventory Turnover	1.28

Taxes

In the past 12 months, BOM:524804 has paid 15.83 billion in taxes.

Income Tax	15.83B
Effective Tax Rate	31.24%

Stock Price Statistics

The stock price has decreased by -7.80% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-7.80%
50-Day Moving Average	1,175.14
200-Day Moving Average	1,268.67
Relative Strength Index (RSI)	44.75
Average Volume (20 Days)	33,791

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, BOM:524804 had revenue of INR 317.24 billion and earned 34.86 billion in profits. Earnings per share was 59.81.

Revenue	317.24B
Gross Profit	186.97B
Operating Income	49.56B
Pretax Income	50.66B
Net Income	34.86B
EBITDA	66.05B
EBIT	49.56B
Earnings Per Share (EPS)	59.81

Full Income Statement

Balance Sheet

The company has 82.36 billion in cash and 82.63 billion in debt, giving a net cash position of -273.70 million.

Cash & Cash Equivalents	82.36B
Total Debt	82.63B
Net Cash	-273.70M
Net Cash Per Share	n/a
Equity (Book Value)	326.47B
Book Value Per Share	562.37
Working Capital	124.80B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 39.25 billion and capital expenditures -19.68 billion, giving a free cash flow of 19.57 billion.

Operating Cash Flow	39.25B
Capital Expenditures	-19.68B
Free Cash Flow	19.57B
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 58.94%, with operating and profit margins of 15.62% and 10.99%.

Gross Margin	58.94%
Operating Margin	15.62%
Pretax Margin	15.97%
Profit Margin	10.99%
EBITDA Margin	20.82%
EBIT Margin	15.62%
FCF Margin	6.17%

Dividends & Yields

BOM:524804 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	0.03%
Buyback Yield	0.53%
Shareholder Yield	n/a
Earnings Yield	5.22%
FCF Yield	2.93%

Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on July 20, 2015. It was a forward split with a ratio of 2.

Last Split Date	Jul 20, 2015
Split Type	Forward
Split Ratio	2

Scores

Altman Z-Score	n/a
Piotroski F-Score	6